Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).

Arcipowski KM, Stunz LL, Graham JP, Kraus ZJ, Vanden Bush TJ, Bishop GA.

J Biol Chem. 2011 Mar 25;286(12):9948-55. doi: 10.1074/jbc.M110.185983. Epub 2011 Jan 24.

2.

TRAF6 is a critical regulator of LMP1 functions in vivo.

Arcipowski KM, Stunz LL, Bishop GA.

Int Immunol. 2014 Mar;26(3):149-58. doi: 10.1093/intimm/dxt052. Epub 2013 Oct 29.

3.

Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1.

Arcipowski KM, Bishop GA.

PLoS One. 2012;7(7):e42478. doi: 10.1371/journal.pone.0042478. Epub 2012 Jul 30.

4.

TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1.

Arcipowski KM, Bishop GA.

J Immunol. 2012 Dec 1;189(11):5165-70. doi: 10.4049/jimmunol.1201821. Epub 2012 Oct 29.

5.

Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.

Graham JP, Moore CR, Bishop GA.

J Immunol. 2009 Sep 1;183(5):2966-73. doi: 10.4049/jimmunol.0900442. Epub 2009 Aug 10.

6.

LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.

Wu S, Xie P, Welsh K, Li C, Ni CZ, Zhu X, Reed JC, Satterthwait AC, Bishop GA, Ely KR.

J Biol Chem. 2005 Sep 30;280(39):33620-6. Epub 2005 Jul 11.

7.

TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.

Kraus ZJ, Nakano H, Bishop GA.

Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17140-5. doi: 10.1073/pnas.0903786106. Epub 2009 Sep 17.

8.

The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.

Shkoda A, Town JA, Griese J, Romio M, Sarioglu H, Knöfel T, Giehler F, Kieser A.

PLoS Biol. 2012;10(8):e1001376. doi: 10.1371/journal.pbio.1001376. Epub 2012 Aug 14.

9.

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G.

Mol Cell Biol. 1996 Dec;16(12):7098-108.

10.
12.

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.

Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.

Oncogene. 1997 Jun 19;14(24):2899-916.

13.

Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.

Graham JP, Arcipowski KM, Bishop GA.

Immunol Rev. 2010 Sep;237(1):226-48. doi: 10.1111/j.1600-065X.2010.00932.x. Review.

PMID:
20727039
14.
15.

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

Greenfeld H, Takasaki K, Walsh MJ, Ersing I, Bernhardt K, Ma Y, Fu B, Ashbaugh CW, Cabo J, Mollo SB, Zhou H, Li S, Gewurz BE.

PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890. eCollection 2015 May.

16.

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, Kikutani H.

Science. 1999 Oct 8;286(5438):300-3.

17.
19.

A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.

Rowland SL, Tremblay MM, Ellison JM, Stunz LL, Bishop GA, Hostager BS.

J Immunol. 2007 Oct 1;179(7):4645-53.

20.

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.

Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E.

J Virol. 1998 Oct;72(10):7900-8.

Supplemental Content

Support Center